
Ainos reports 499% revenue growth & AI Nose expansion
Ainos (NASDAQ:AIMD) reported a pivotal fiscal year 2025, characterized by a roughly 499% surge in revenue and a successful transition into high-volume industrial markets.
The company, which specializes in "SmellTech" digitization, saw its gross margin swing from a loss in 2024 to a positive 82.9% in 2025, reflecting the commercial maturation of its proprietary AI Nose platform.
The financial recovery was bolstered by a New Taiwan Dollar 90 million financing (approximately $2.82 million) secured in March 2026.
This capital injection is earmarked to support a scaled rollout of its sensing systems within the semiconductor sector.
Management confirmed that early 2026 operations are already underway, including the targeted installation of 200 front-end systems for technical validation in wafer fabrication facilities.
A central pillar of the company’s growth strategy is a three-year, $2.1 million subscription program for 1,400 back-end semiconductor systems.
Ainos has already received initial customer deposits for this phase and outlined a broader strategic roadmap that contemplates expanding the deployment to as many as 20,000 systems.
Analysts suggest such a scale could represent an annual subscription value approaching $10 million if fully realized.
Beyond hardware, Ainos is focusing on the monetization of its "Smell ID" data and the "Smell Language Model" (SLM).
More from United States
AbbVie revenue increases 10.3% to $17.4 billion in third quarter
Sensient Q3 revenue rockets 10.6% to $455.8 million
Cameco Q3 adjusted loss reaches CA$2 million as uranium output falls
Kite Realty Q3 loss narrows to $13.3 million as NOI grows
Largo cuts 2026 vanadium production outlook to 9,500–10,500 tonnes
nVent Q3 sales jump 44% as shares fall despite higher revenue